A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

Local Institution - 804, Camperdown

Local Institution - 904, Antwerp

Local Institution - 501, Copenhagen

Local Institution - 901, Leuven

Local Institution - 803, Melbourne

Local Institution - 806, Fitzroy

Local Institution - 151, Seoul

Local Institution - 805, Clayton

Local Institution - 802, Adelaide

Local Institution - 502, Odense

Local Institution - 902, Yvoir

Local Institution - 905, Ghent

Local Institution - 406, Cáceres

Local Institution - 104, New York

Local Institution - 001, Athens

Local Institution - 111, Buffalo

Local Institution - 112, Charlottesville

Local Institution - 404, Madrid

Local Institution - 409, Pozuelo de Alarcón

Local Institution - 108, Spartanburg

Local Institution - 102, Atlanta

Local Institution - 401, Pamplona

Local Institution - 402, Salamanca

Local Institution - 101, Nashville

Local Institution - 408, Santander

Local Institution - 405, Valencia

Local Institution - 106, Houston

Local Institution - 109, Seattle

Local Institution - 103, Duarte

Local Institution - 105, Boston

Local Institution - 201, Calgary

Local Institution - 204, London

Local Institution - 205, Ottawa

Local Institution - 202, Toronto

Local Institution - 206, Montreal

Local Institution - 203, Québec

Local Institution - 503, Aarhus N

Local Institution - 601, Helsinki

Local Institution - 705, Chuo-ku,chiba

Local Institution - 703, Fukuoka

Local Institution - 704, Kashiwa

Local Institution - 702, Kobe

Local Institution - 706, Kyoto

Local Institution - 701, Okayama

Local Institution - 152, Seoul

Local Institution - 150, Seoul

Local Institution - 403, Badalona (Barcelona)

Local Institution - 407, Barcelona

Local Institution - 304, Plymouth

Local Institution - 306, Cardiff

Local Institution - 303, London

Local Institution - 305, Newcastle upon Tyne

Local Institution - 302, Oxford

Local Institution - 301, Sutton